A New Dose‐Finding Design for Bivariate Outcomes
From MaRDI portal
Publication:3433237
Recommendations
- Adaptive designs for dose-finding based on efficacy-toxicity response
- Adaptive designs for selecting drug combinations based on efficacy-toxicity response
- Dose-Finding Based on Efficacy-Toxicity Trade-Offs
- Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios
- Two‐Dimensional Dose Finding in Discrete Dose Space
Cites work
Cited in
(15)- Penalized optimal designs for dose-finding
- Prediction Approaches to Sequentially Searching for an Optimal Dose
- Correlated endpoints: simulation, modeling, and extreme correlations
- Adaptive designs for dose-finding based on efficacy-toxicity response
- Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
- Adaptive clinical trial designs for phase I cancer studies
- Up-and-Down Designs for Selecting the Dose with Maximum Success Probability
- A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages
- Cumulative cohort design for dose-finding
- Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach
- Optimizing the concentration and bolus of a drug delivered by continuous infusion
- Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
- Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials
- Bayesian models and decision algorithms for complex early phase clinical trials
This page was built for publication: A New Dose‐Finding Design for Bivariate Outcomes
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3433237)